Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

Feikin, D. R., Higdon, M. M., Abu-Raddad, L. J., Andrews, N., Araos, R., Goldberg, Y., Groome, M. J., Huppert, A., O'Brien, K. L., Smith, P. G., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00152-0 · Cited by 1,237 · see citing works

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity

Tenforde, M. W., Self, W. H., Adams, K., Gaglani, M., Ginde, A. A., McNeal, T., Ghamande, S., Douin, D. J., Talbot, H. K., Casey, J. D., et al. (2021) · JAMA · doi:10.1001/jama.2021.19499 · Cited by 633 · see citing works

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

Thompson, M. G., Stenehjem, E. A., Grannis, S. J., Ball, S. W., Naleway, A. L., Ong, T. C., DeSilva, M. B., Natarajan, K., Bozio, C. H., Lewis, N., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2110362 · Cited by 459 · see citing works

Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron

Liu, J., Chandrashekar, A., Sellers, D., Barrett, J., Jacob-Dolan, C., Lifton, M. A., McMahan, K., Sciacca, M., VanWyk, H., Wu, C., et al. (2022) · Nature · doi:10.1038/s41586-022-04465-y · Cited by 451 · see citing works

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

Ferdinands, J. M., Rao, S., Dixon, B. E., Mitchell, P. K., DeSilva, M. B., Irving, S. A., Lewis, N., Natarajan, K., Stenehjem, E., Grannis, S. J., et al. (2022) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7107e2 · Cited by 435 · see citing works

Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance

Britton, A., Fleming-Dutra, K. E., Shang, N., Smith, Z., Dorji, T., Derado, G., Accorsi, E. K., Ajani, U. A., Miller, J., Schrag, S. J., et al. (2022) · JAMA · doi:10.1001/jama.2022.2068 · Cited by 91 · see citing works

Immune-mediated attenuation of influenza illness after infection: opportunities and challenges

Patel, M. M., York, I. A., Monto, A. S., Thompson, M. G., & Fry, A. M. (2021) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00180-4 · Cited by 56 · see citing works

Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study

McMenamin, M. E., Nealon, J., Lin, Y., Wong, J. Y., Cheung, J. K., Lau, E. H. Y., Wu, P., Leung, G. M., & Cowling, B. J. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00345-0 · Cited by 360 · see citing works

Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar

Chemaitelly, H., Ayoub, H. H., AlMukdad, S., Coyle, P., Tang, P., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30895-3 · Cited by 228 · see citing works

Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods — United States, April 2020–June 2022

Adjei, S., Hong, K., Molinari, N., Bull–Otterson, L., Ajani, U. A., Gundlapalli, A. V., Harris, A. M., Hsu, J., Kadri, S. S., Starnes, J., et al. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7137a4 · Cited by 191 · see citing works

COVID-19 Vaccination Coverage, by Race and Ethnicity — National Immunization Survey Adult COVID Module, United States, December 2020–November 2021

Kriss, J. L., Hung, M.-C., Srivastav, A., Black, C. L., Lindley, M. C., Lee, J. T., Koppaka, R., Tsai, Y., Lu, P.-J., Yankey, D., et al. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7123a2 · Cited by 181 · see citing works

mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications

Wang, Y., Kumari, M., Chen, G., Hong, M.-H., Yuan, J. P., Tsai, J.-L., & Wu, H. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00977-5 · Cited by 183 · see citing works

IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein

Uversky, V. N., Redwan, E. M. M. M., Makis, W., & Rubio‐Casillas, A. (2023) · Vaccines · doi:10.3390/vaccines11050991 · Cited by 118 · see citing works

Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 — COVID-NET, 10 States, March 2020–February 2022

Singson, J. R. C., Kirley, P. D., Pham, H., Rothrock, G., Armistead, I., Meek, J. I., Anderson, E. J., Reeg, L., Lynfield, R., Ropp, S. L., et al. (2022) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7127a3 · Cited by 95 · see citing works

Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization

Feikin, D. R., Abu-Raddad, L. J., Andrews, N., Davies, M.-A., Higdon, M. M., Orenstein, W. A., & Patel, M. K. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.04.069 · Cited by 83 · see citing works

Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods

Link‐Gelles, R., Levy, M. E., Natarajan, K., Reese, S. E., Naleway, A. L., Grannis, S. J., Klein, N. P., DeSilva, M. B., Ong, T. C., Gaglani, M., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.2598 · Cited by 91 · see citing works

Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study

Tsang, N. N. Y., So, H. C., Cowling, B. J., Leung, G. M., & Ip, D. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00732-0 · Cited by 77 · see citing works

Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA

Mello, M. M., Opel, D. J., Benjamin, R. M., Callaghan, T., DiResta, R., Elharake, J. A., Flowers, L., Galvani, A. P., Salmon, D. A., Schwartz, J. L., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00875-3 · Cited by 72 · see citing works

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022

de Gier, B., van Asten, L., Boere, T. M., van Roon, A. M., van Roekel, C., Pijpers, J., van Werkhoven, C. H., van den Ende, C., Hahné, S. J. M., de Melker, H. E., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.06.005 · Cited by 60 · see citing works

SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines

Pather, S., Madhi, S. A., Cowling, B. J., Moss, P. A. H., Kamil, J. P., Ciesek, S., Muik, A., & Türeci, Ö. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1130539 · Cited by 59 · see citing works

Misleading Beyond Visual Tricks: How People Actually Lie with Charts

Lisnic, M., Polychronis, C., Lex, A., & Kogan, M. (2023) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3544548.3580910 · Cited by 60 · see citing works

An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations

Westberg, M., Su, Y., Zou, X., Huang, P., Rustagi, A., Garhyan, J., Patel, P. B., Fernández, D., Wu, Y., Hao, C., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0979 · Cited by 47 · see citing works

Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period — IVY Network, 19 U.S. States, February 1, 2022–January 31, 2023

DeCuir, J., Surie, D., Zhu, Y., Gaglani, M., Ginde, A. A., Douin, D. J., Talbot, H. K., Casey, J. D., Mohr, N. M., McNeal, T., et al. (2023) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7217a3 · Cited by 41 · see citing works

Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study

Farroni, C., Aiello, A., Diamanti, A. P., Laganà, B., Petruccioli, E., Agrati, C., Garbuglia, A. R., Meschi, S., Lapa, D., Cuzzi, G., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.10.035 · Cited by 39 · see citing works

Estimation of Vaccine Effectiveness of CoronaVac and BNT162b2 Against Severe Outcomes Over Time Among Patients With SARS-CoV-2 Omicron

Wei, Y., Jia, K. M., Zhao, S., Hung, C. T., Mok, C. K. P., Poon, P. K.-M., Leung, E. Y. M., Wang, M. H., Yam, C. H. K., Chow, T. Y., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.54777 · Cited by 39 · see citing works

Association of 2024–2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. Veterans

Cai, M., Xie, Y., & Al‐Aly, Z. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2510226 · Cited by 39 · see citing works

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave

Kawano, Y., Patel, N. J., Wang, X., Cook, C., Vanni, K. M. M., Kowalski, E. N., Banasiak, E., Qian, G., DiIorio, M. A., Hsu, T. Y. T., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-222954 · Cited by 37 · see citing works

Hospitalized Patients With Severe Coronavirus Disease 2019 During the Omicron Wave in Israel: Benefits of a Fourth Vaccine Dose

(2022) · doi:10.1093/cid/ciac501 · Cited by 35 · see citing works

Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies

Song, S., Madewell, Z. J., Liu, M., Longini, I. M., & Yang, Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1195908 · Cited by 34 · see citing works

Prevalence and Severity of Symptoms 3 Months After Infection With SARS-CoV-2 Compared to Test-Negative and Population Controls in the Netherlands

van der Maaden, T., Mutubuki, E. N., de Bruijn, S., Leung, K. Y., Knoop, H., Slootweg, J., Tulen, A. D., Wong, A., van Hoek, A. J., Franz, E., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac474 · Cited by 34 · see citing works

Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022

Kojima, N., Adams, K., Self, W. H., Gaglani, M., McNeal, T., Ghamande, S. A., Steingrub, J. S., Shapiro, N. I., Duggal, A., Busse, L. W., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad276 · Cited by 34 · see citing works

Post-COVID conditions following COVID-19 vaccination: a retrospective matched cohort study of patients with SARS-CoV-2 infection

Malden, D. E., Liu, I. A., Qian, L., Sy, L. S., Lewin, B. J., Asamura, D. T., Ryan, D. S., Bezi, C., Williams, J. T. B., Kaiser, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48022-9 · Cited by 32 · see citing works

Current Challenges With the Use of Test-Negative Designs for Modeling COVID-19 Vaccination and Outcomes

Shi, X., Li, K. Q., & Mukherjee, B. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac203 · Cited by 31 · see citing works

Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies

Aiello, A., Coppola, A., Ruggieri, S., Farroni, C., Altera, A. M. G., Salmi, A., Vanini, V., Cuzzi, G., Petrone, L., Meschi, S., et al. (2022) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2022-330175 · Cited by 31 · see citing works

Effectiveness of COVID-19 Vaccines against SARS-CoV-2 Omicron Variant (B.1.1.529): A Systematic Review with Meta-Analysis and Meta-Regression

Pratama, N. R., Wafa, I. A., Budi, D. S., Sutanto, H., Asmarawati, T. P., Barlian Effendi, G., & Wungu, C. D. K. (2022) · Vaccines · doi:10.3390/vaccines10122180 · Cited by 30 · see citing works

Influenza Vaccine Effectiveness Against Hospitalizations and Emergency Department or Urgent Care Encounters for Children, Adolescents, and Adults During the 2023–2024 Season, United States

Tenforde, M. W., Reeves, E. L., Weber, Z. A., Tartof, S. Y., Klein, N. P., Dascomb, K. K., DeSilva, M. B., Yang, D., Grannis, S. J., Irving, S. A., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae597 · Cited by 30 · see citing works

Return on Investment of the COVID-19 Vaccination Campaign in New York City

Sah, P., VILCHES, T. N., Moghadas, S. M., Pandey, A., Gondi, S., Schneider, E. C., Singer, J., Chokshi, D. A., & Galvani, A. P. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.43127 · Cited by 30 · see citing works

Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis

Rahman, M. O., Kamigaki, T., Thandar, M. M., Haruyama, R., Yan, F., Shibamura-Fujiogi, M., Khin Maung Soe, J., Islam, M. R., Yoneoka, D., Miyahara, R., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-076892 · Cited by 29 · see citing works

Probing the biophysical constraints of SARS-CoV-2 spike N-terminal domain using deep mutational scanning

Ouyang, W. O., Tan, T. J. C., Lei, R., Song, G., Kieffer, C., Andrabi, R., Matreyek, K. A., & Wu, N. C. (2022) · Science Advances · doi:10.1126/sciadv.add7221 · Cited by 26 · see citing works

Trends in Severe Outcomes Among Adult and Pediatric Patients Hospitalized With COVID-19 in the Canadian Nosocomial Infection Surveillance Program, March 2020 to May 2022

Mitchell, R., Cayen, J., Thampi, N., Frenette, C. H., Bartoszko, J. J., Choi, K. B., Comeau, J. L., Conly, J. M., Ellis, C., Ellison, J., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.9050 · Cited by 25 · see citing works

Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023

Griggs, E. P., Mitchell, P. K., Lazariu, V., Gaglani, M., McEvoy, C., Klein, N. P., Valvi, N. R., Irving, S. A., Kojima, N., Stenehjem, E. A., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad505 · Cited by 27 · see citing works

Association Between Vaccination Status and Outcomes in Patients Admitted to the ICU With COVID-19*

van Diepen, S., McAlister, F. A., Chu, L. M., Youngson, E. R. E., Kaul, P., & Kadri, S. S. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005928 · Cited by 25 · see citing works

Persistence and Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination in a West Virginia Nursing Home Cohort

Smoot, K., Yang, J., Tacker, D. H., Welch, S., Khodaverdi, M., Kimble, W., Wen, S., Amjad, A., Marsh, C. B., Perrotta, P. L., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.31334 · Cited by 23 · see citing works

Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: A population-based, matched cohort study

COVID-19 Omicron Delta study group (2023) · PLoS ONE · doi:10.1371/journal.pone.0282806 · Cited by 23 · see citing works

Exploring COVID-19 Vaccine Attitudes among Racially and Ethnically Minoritized Communities: Community Partners’ and Residents’ Perspectives

Leal, I. M., Njoh, J., Chen, T. A., Foreman-Hays, F., Reed, B. C., Haley, S. A., Chávez, K., Reitzel, L. R., & Obasi, E. M. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043372 · Cited by 22 · see citing works

COVID-19 Vaccine Effectiveness Against Progression to In-Hospital Mortality in Zambia, 2021–2022

Chanda, D. M., Hines, J. Z., Itoh, M., Fwoloshi, S., Minchella, P. A., Zyambo, K., Sivile, S., Kampamba, D., Chirwa, B., Chanda, R., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac469 · Cited by 20 · see citing works

How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development

Duan, Q., Hu, T., Zhu, Q., Jin, X., Chi, F., & Chen, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974433 · Cited by 20 · see citing works

Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?

Sritipsukho, P., Khawcharoenporn, T., Siribumrungwong, B., Damronglerd, P., Suwantarat, N., Satdhabudha, A., Chaiyakulsil, C., Sinlapamongkolkul, P., Tangsathapornpong, A., Bunjoungmanee, P., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2174779 · Cited by 20 · see citing works

Rural-Urban Disparities in Hospital Admissions and Mortality Among Patients with COVID-19: Evidence from South Carolina from 2021 to 2022

Giannouchos, T. V., Li, Z., Hung, P., Li, X., & Olatosi, B. (2023) · Journal of Community Health · doi:10.1007/s10900-023-01216-6 · Cited by 17 · see citing works

Estimated Effectiveness of 2024-2025 COVID-19 Vaccination Against Severe COVID-19

Ma, K. C., Webber, A. E., Lauring, A. S., Bendall, E. E., Papalambros, L., Safdar, B., Ginde, A. A., Peltan, I. D., Brown, S. M., Gaglani, M., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.57415 · Cited by 16 · see citing works

Immunogenicity, clinical efficacy and safety of additional second COVID‐19 booster vaccines against Omicron and its subvariants: A systematic review

Chenchula, S., Chandra, M. B., Adusumilli, M. B., Ghanta, S. N., Bommasani, A., Anitha, K., Padmavathi, R., Amerneni, K. C., Chikatipalli, R., Ghanta, M. K., et al. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2515 · Cited by 16 · see citing works

Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19—VISION Network, August 2021 to March 2022

DeSilva, M. B., Mitchell, P. K., Klein, N. P., Dixon, B. E., Tenforde, M. W., Thompson, M. G., Naleway, A. L., Grannis, S. J., Ong, T. C., Natarajan, K., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac458 · Cited by 14 · see citing works

Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City

Saxena, A., Engel, A., Banbury, B., Hasan, G., Fraser, N., Zaminski, D. H., Masson, M., Haberman, R. H., Scher, J. U., Ho, G. H., et al. (2022) · The Lancet Rheumatology · doi:10.1016/s2665-9913(22)00190-4 · Cited by 14 · see citing works

A Phase 2 Randomized Trial Evaluating the Antiviral Activity and Safety of the Direct-Acting Antiviral Bemnifosbuvir in Ambulatory Patients with Mild or Moderate COVID-19 (MOONSONG Study)

Boffito, M., Dolan, E., Singh, K., Holmes, W. C., Wildum, S., Horga, A., Pietropaolo, K., Zhou, X., Clinch, B., Collinson, N., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00077-23 · Cited by 13 · see citing works

COVID-19 Vaccination reduced pneumonia severity

Wada, N., Li, Y., Hino, T., Gagne, S. M., Valtchinov, V. I., Gay, E. B., Nishino, M., Madore, B., Guttmann, C. R. G., Bond, S. A., et al. (2022) · European Journal of Radiology Open · doi:10.1016/j.ejro.2022.100456 · Cited by 13 · see citing works

Antibodies to S2 domain of SARS-CoV-2 spike protein in Moderna mRNA vaccinated subjects sustain antibody-dependent NK cell-mediated cell cytotoxicity against Omicron BA.1

Balinsky, C. A., Jiang, L., Jani, V., Cheng, Y., Zhang, Z., Belinskaya, T., Qiu, Q., Long, T. K., Schilling, M. A., Jenkins, S. A., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1266829 · Cited by 12 · see citing works

Monitoring COVID‐19 vaccine effectiveness against COVID‐19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022

Kislaya, I., Sentís, A., Starrfelt, J., Nunes, B., Martínez‐Baz, I., Nielsen, K. F., Alkerwi, A., Braeye, T., Fontán‐Vela, M., Bacci, S., et al. (2023) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.13195 · Cited by 12 · see citing works

Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis

Bolze, A., Mogensen, T. H., Zhang, S., Abel, L., Andreakos, E., Arkin, L. M., Borghesi, A., Brodin, P., Hagin, D., Novelli, G., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01372-9 · Cited by 12 · see citing works

COVID-19 vaccine booster significantly decreases the risk of intensive care unit hospitalization in heart failure patients during the Omicron variant wave: A population-based study

Pařenica, J., Benešová, K., Radvan, M., Sanca, O., Hlásenský, J., Lokaj, P., Ondrúš, T., Helánová, K., Kala, P., Dušek, L., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.998842 · Cited by 12 · see citing works

Resilient Regions in Brazil: Unfolding the Effects of COVID-19 From a Socioeconomic Perspective

Tupy, I. S., Silva, F. F., Diniz, G. F. C., Montenegro, R. L. G., Stein, A. D. Q., & Ferraz, D. E. (2022) · International Regional Science Review · doi:10.1177/01600176221145878 · Cited by 12 · see citing works

Effectiveness of mRNA vaccine against Omicron-related infections in the real world: A systematic review and meta-analysis

Guo, K., Ni, P., Chang, S., Jin, Y., Duan, G., & Zhang, R. (2023) · American Journal of Infection Control · doi:10.1016/j.ajic.2023.02.005 · Cited by 12 · see citing works

Cost-effectiveness of nirmatrelvir/ritonavir for high-risk adult outpatients with COVID-19 in Japan

Mizuno, T., Kondo, Y., Sakai, M., Saneyasu, K., Kojima, R., & Miyake, Y. (2024) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2024.02.001 · Cited by 12 · see citing works

Excess Death Rates by State During the COVID-19 Pandemic: United States, 2020‒2023

Woolf, S. H., Lee, J. H., Chapman, D. A., Sabo, R., & Zimmerman, E. B. (2024) · American Journal of Public Health · doi:10.2105/ajph.2024.307731 · Cited by 11 · see citing works

COVID-19 Vaccine Effectiveness during a Prison Outbreak when Omicron was the Dominant Circulating Variant—Zambia, December 2021

Simwanza, J., Hines, J. Z., Sinyange, D., Sinyange, N., Mulenga, C., Hanyinza, S., Sakubita, P., Langa, N., Nowa, H., Gardner, P. N., et al. (2022) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.22-0368 · Cited by 11 · see citing works

Vaccination Status and Trends in Adult Coronavirus Disease 2019–Associated Hospitalizations by Race and Ethnicity: March 2020–August 2022

Ko, J. Y., Pham, H., Anglin, O., Chai, S. J., Alden, N. B., Meek, J. I., Anderson, E. J., Weigel, A., Kohrman, A., Lynfield, R., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad266 · Cited by 11 · see citing works

Selection Effects and COVID-19 Mortality Risk after Pfizer vs. Moderna Vaccination: Evidence from Linked Mortality and Vaccination Records

Atanasov, V. A., Barreto, N., Whittle, J., Meurer, J., Weston, B. W., Luo, Q., Yuan, A. Y., Franchi, L., Zhang, R., & Black, B. S. (2023) · Vaccines · doi:10.3390/vaccines11050971 · Cited by 11 · see citing works

Public Discourse, User Reactions, and Conspiracy Theories on the X Platform About HIV Vaccines: Data Mining and Content Analysis

Zhang, J., Wang, Y. J., Mouton, M., Zhang, J., & Shi, M. (2024) · Journal of Medical Internet Research · doi:10.2196/53375 · Cited by 10 · see citing works

Projected Health Outcomes Associated With 3 US Supreme Court Decisions in 2022 on COVID-19 Workplace Protections, Handgun-Carry Restrictions, and Abortion Rights

Gaffney, A. W., Himmelstein, D. U., Dickman, S., Myers, C. K., Hemenway, D., McCormick, D., & Woolhandler, S. J. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.15578 · Cited by 10 · see citing works

Comparisons of Pediatric and Adult SARS-CoV-2-Specific Antibodies up to 6 Months after Infection, Vaccination, or Hybrid Immunity

Kim, M., Cheng, W. A., Congrave‐Wilson, Z., Ruiz, C. J. M., Turner, L. S., Mendieta, S., Jumarang, J., Valle, J. D., Lee, Y., Fabrizio, T. P., et al. (2023) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piad107 · Cited by 9 · see citing works

Association between COVID-19 mRNA vaccination and COVID-19 illness and severity during Omicron BA.4 and BA.5 sublineage periods

Link-Gelles, R., Levy, M. E., Natarajan, K., Reese, S. E., Naleway, A. L., Grannis, S. J., Klein, N. P., DeSilva, M. B., Ong, T. C., Gaglani, M., et al. (2022) · doi:10.1101/2022.10.04.22280459 · Cited by 10 · see citing works

A SARS-CoV-2 outbreak associated with vaccine breakthrough in an acute care hospital

Park, S. Y., Kim, T. H., Lee, E. J., Loeb, M. B., Jeong, Y. S., Kim, J. H., Oh, S. M., Cheong, S., Park, H., Jo, S., et al. (2022) · American Journal of Infection Control · doi:10.1016/j.ajic.2022.05.010 · Cited by 9 · see citing works

The numerical solution of a mathematical model of the Covid-19 pandemic utilizing a meshless local discrete Galerkin method

Asadi‐Mehregan, F., Assari, P., & Dehghan, M. (2022) · Engineering With Computers · doi:10.1007/s00366-022-01749-9 · Cited by 9 · see citing works

Impact of COVID-19 on Patients Hospitalized with ST-Segment Elevation Myocardial Infarction in the United States during the Early Pandemic: An Analysis of Outcomes, Care Delivery, and Racial Disparities in Mortality

Majeed, H., Gangu, K., Shekhar, R., Sagheer, S., Garg, I., Shuja, H., Bobba, A., Chourasia, P. K., Avula, S. R., & Sheikh, A. B. (2023) · Infectious Disease Reports · doi:10.3390/idr15010006 · Cited by 9 · see citing works

CROI 2025: Acute and Postacute COVID-19

Antar, A. A. R., & Peluso, M. J. (2025) · Topics in antiviral medicine · doi:10.68040/2025333.555568 · Cited by 9 · see citing works

Fostamatinib for Hospitalized Adults With COVID-19 and Hypoxemia

Collins, S. P., Shotwell, M. S., Strich, J. R., Gibbs, K. W., de Wit, M., Files, D. C., Harkins, M. S., Hudock, K. M., Merck, L. H., Moskowitz, A., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.48215 · Cited by 8 · see citing works

Understanding the vaccine stance of Italian tweets and addressing language changes through the COVID-19 pandemic: Development and validation of a machine learning model

Cheatham, S., Kummervold, P. E., Parisi, L., Lanfranchi, B., Croci, I., Comunello, F., Rota, M. C., Filia, A., Tozzi, A. E., Rizzo, C., et al. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.948880 · Cited by 8 · see citing works

Understanding risk factors of a new variant outburst through global analysis of Omicron transmissibility

Djordjević, M., Marković, S. S., Salom, I., & Djordjevic, M. (2022) · Environmental Research · doi:10.1016/j.envres.2022.114446 · Cited by 8 · see citing works

COVID-19 and NSTEMI Outcomes among Hospitalized Patients in the United States and Racial Disparities in Mortality: Insight from National Inpatient Sample Database

Majeed, H., Gangu, K., Sagheer, S., Garg, I., Khan, U., Shuja, H., Bobba, A., Chourasia, P. K., Shekhar, R., Avula, S. R., et al. (2022) · Vaccines · doi:10.3390/vaccines10122024 · Cited by 8 · see citing works

Evaluation of mortality risk after COVID-19 vaccination, Utah 2021

Payne, J. R., Bose, S., Kubiak, R. W., & Nolen, L. D. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.03.072 · Cited by 8 · see citing works

Qualitative analysis of community pharmacy–based COVID-19 immunization service operations

McCormick, N. P., Jackson, B. N., Durham, S. H., Hohmann, N. S., & Westrick, S. C. (2023) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2023.06.022 · Cited by 8 · see citing works

Effectiveness of inactivated COVID-19 vaccines in preventing COVID-19-related hospitalization during the Omicron BF.7-predominant epidemic wave in Beijing, China: a cohort study

Zhao, D., Sun, Y., Li, J., Li, X., Ma, Y., Cao, Z., Zhang, J., Ma, J., Li, J., Wang, Q., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09889-7 · Cited by 7 · see citing works

Description of Hospitalizations due to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Based on Vaccination Status

Moffa, M. A., Shively, N. R., Carr, D. R., Bremmer, D. N., Buchanan, C., Trienski, T. L., Jacobs, M. W., Saini, V., & Walsh, T. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac438 · Cited by 7 · see citing works

Mortality Rates by Age Group and Intubation Status in Hospitalized Adult Patients From 21 United States Hospital Systems During Three Surges of the COVID-19 Pandemic

Nolan, M. B., Nolan, M. E., Piasecki, T. M., & Fiore, M. C. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.01.029 · Cited by 7 · see citing works

Assessing How Risk Communication Surveillance Prompts COVID-19 Vaccine Acceptance Among Internet Users by Applying the Situational Theory of Problem Solving: Cross-Sectional Study

Jin, Q., Raza, S. H., Yousaf, M., Zaman, U., Ogadimma, E. C., Shah, A. A., Core, R. S., & Malik, A. N. (2023) · JMIR Formative Research · doi:10.2196/43628 · Cited by 6 · see citing works

Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort

Machado, K. L. L. L., Burian, A. P. N., Martins‐Filho, O. A., Mill, J. G., Ferreira, L. B., Tapia, K. R. L., Moulin, A. C. S., Moulaz, I. R., Ribeiro, P. D. C., Magalhães, V. D. O., et al. (2024) · Vaccines · doi:10.3390/vaccines12121367 · Cited by 6 · see citing works

Nanotechnology Assisted Strategies to Tackle COVID and Long-COVID

Aadil, K. R., Bhange, K., Mishra, G., Sahu, A., Sharma, S., Pandey, N., Mishra, Y. K., Kaushik, A. K., & Kumar, R. (2025) · BioNanoScience · doi:10.1007/s12668-025-01812-x · Cited by 6 · see citing works

YouTube and COVID-19 vaccines: A mini scoping review

Narayanan, S., & Basch, C. H. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2202091 · Cited by 6 · see citing works

Distinct Clinical Presentations and Outcomes of Hospitalized Adults with the SARS-CoV-2 Infection Occurring during the Omicron Variant Surge

Niu, J., Kim, M., Jalal, A. T., Goldberg, J. E., Martinez, E. M. A., Moscoso, N. P. S., Rubio-Gomez, H., Mayer, D., Visbal, A., Sareli, C., et al. (2023) · Healthcare · doi:10.3390/healthcare11121703 · Cited by 6 · see citing works

COVID-19 in the US-affiliated Pacific Islands: A timeline of events and lessons learned from March 2020–November 2022

McGinley, H. L. C., Hancock, W. T., Kern-Allely, S., Jenssen, M., Chutaro, E., Camacho, J., Judicpa, P., Okumura, K., Muñoz, N., Ademokun, O., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002052 · Cited by 6 · see citing works

Pandemic-related posttraumatic psychological growth in U.S. military veterans: A 3-year, nationally representative, longitudinal study

Kang, H., Na, P. J., Fischer, I. C., Tsai, J., Tedeschi, R. G., & Pietrzak, R. H. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115370 · Cited by 5 · see citing works

Expert consensus on the diagnosis and treatment of severe and critical coronavirus disease 2019 (COVID-19)

Shang, Y., Wu, J., Liu, J., Long, Y., Xie, J., Zhang, D., Hu, B., Zong, Y., Liao, X., Shang, X., et al. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.07.001 · Cited by 5 · see citing works

COVID-19 Vaccination Safety Profiles in Patients With Solid Tumour Cancers: A Systematic Review

Shear, S. L., Shams, K., Weisberg, J., Hamidi, N., & Scott, S. C. (2023) · Clinical Oncology · doi:10.1016/j.clon.2023.03.006 · Cited by 5 · see citing works

Anti‐science conspiracies pose new threats to US biomedicine in 2023

Hotez, P. J. (2023) · FASEB BioAdvances · doi:10.1096/fba.2023-00032 · Cited by 5 · see citing works

Long-Term Analyses of SARS-CoV-2 Humoral and T Cell Responses and Breakthrough SARS-CoV-2 Infections after Two Doses of BNT162b2 Followed by mRNA-1273 and Bivalent Omicron-Adapted BNT162b2 Vaccines: A Prospective Study over 2 Years in Non-Immunocompromised Individuals

Erice, A., Prieto, L., & Caballero, C. (2023) · Vaccines · doi:10.3390/vaccines11121835 · Cited by 5 · see citing works

Prior COVID-19 Diagnosis, Severe Outcomes, and Long COVID among U.S. Adults, 2022

Nguyen, K. H., Bao, Y., Chen, S., Bednarczyk, R. A., Vasudevan, L., & Corlin, L. (2024) · Vaccines · doi:10.3390/vaccines12060669 · Cited by 5 · see citing works

Tracking vaccine effectiveness in an evolving pandemic, countering misleading hot takes and epidemiologic fallacies

Morris, J. S. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae280 · Cited by 5 · see citing works

Longitudinal evaluation of the impact of immunosuppressive regimen on immune responses to COVID-19 vaccination in kidney transplant recipients

Wiedemann, A., Pellaton, C., Dekeyser, M., Guillaumat, L., Déchenaud, M., Krief, C., Lacabaratz, C., Grimbert, P., Pantaleo, G., Lévy, Y., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.978764 · Cited by 5 · see citing works

Impact of the COVID-19 Vaccination Program on case incidence, emergency department visits, and hospital admissions among children aged 5–17 Years during the Delta and Omicron Periods—United States, December 2020 to April 2022

Topf, K. G., Sheppard, M., Marx, G. E., Wiegand, R. E., Link‐Gelles, R., Binder, A. M., Cool, A. J., Lyons, B. C., Park, S., Fast, H. E., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276409 · Cited by 5 · see citing works

Influenza

Neumann, G., Cowling, B. J., Chen, H., Stertz, S., Manicassamy, B., Barr, I., Uyeki, T. M., & Kawaoka, Y. (2026) · Nature Reviews Disease Primers · doi:10.1038/s41572-026-00727-5 · Cited by 5 · see citing works

Population-Level Effectiveness of an Inactivated Whole-Virion COVID-19 Vaccine: A Test Negative Case-Control Study in the Dominican Republic

Pérez-Then, E. N., Miric, M., Qian, H., Chen, Y. Q., Wang, Y., Vallejo, V., Quezada, W., Flaquer, M., Olivo, J., Castillo, J. C., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad075 · Cited by 4 · see citing works

Cost effectiveness analysis comparing varying booster intervals of vaccination policies to address COVID-19 situation in Thailand, 2023

Mahasing, C., Suphanchaimat, R., Teekasap, P., Nittayasoot, N., Wongsanuphat, S., & Thammawijaya, P. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310427 · Cited by 4 · see citing works

Association between COVID-19 Primary Vaccination and Severe Disease Caused by SARS-CoV-2 Delta Variant among Hospitalized Patients: A Belgian Retrospective Cohort Study

Robalo, Q., Mot, L. D., Vandromme, M., Goethem, N. V., Gabrio, A., Chung, P. Y. J., Meurisse, M., Catteau, L., Thijs, C. T., & Blot, K. Y. (2022) · Vaccines · doi:10.3390/vaccines11010014 · Cited by 4 · see citing works

Clinical Characteristics and Outcomes of Vaccinated VS Non-Vaccinated Critically Ill COVID-19 Patients: Retrospective Observation Study

AlQahtani, S. Y., Alabdulqader, A. A., Mashhour, W. A. A., Aldawood, Z. M., Masari, O. A. A., Alotaibi, T., AlGhamdi, Z. M., Alzahrani, I. M., & Albaloushi, N. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s411299 · Cited by 4 · see citing works

Hyperglycemia Associated With Raynaud Phenomenon and Liver Dysfunction After COVID-19 Vaccination in Type 1 Diabetes Mellitus

Zavgorodneva, Z., Zhang, C. J., Bondiuk, M., & Zahedi, T. (2023) · AACE Clinical Case Reports · doi:10.1016/j.aace.2023.05.006 · Cited by 4 · see citing works

Comparative Evaluation of the Clinical Severity of COVID-19 of Vaccinated and Unvaccinated Patients in Southeastern Romania in the First 6 Months of 2022, during the Omicron Wave

Manole, C., Baroiu, L., Nechita, A., Voinescu, D. C., Ciubară, A., Debita, M., Tatu, A. L., Ciubara, A. B., Ștefanopol, I. A., Anghel, L., et al. (2023) · Healthcare · doi:10.3390/healthcare11152184 · Cited by 4 · see citing works

Pretransplantation coronavirus disease 2019 vaccination requirements: A matched case-control study of factors associated with waitlist inactivation

Edwards, A. L., Tavakol, M., Mello, A., Kerney, J., & Roberts, J. P. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.09.009 · Cited by 4 · see citing works

Misleading Beyond Visual Tricks: How People Actually Lie with ChartsPreprint

Lisnic, M., Polychronis, C., Lex, A., & Kogan, M. (2022) · doi:10.31219/osf.io/ky6th · Cited by 4 · see citing works

Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period — IVY Network, 19 U.S. States, February 1, 2022–January 31, 2023

DeCuir, J., Surie, D., Zhu, Y., Gaglani, M., Ginde, A. A., Douin, D. J., Talbot, H. K., Casey, J. D., Mohr, N. M., McNeal, T., et al. (2023) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7217a3 · Cited by 41 · see citing works

COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study)

Arashiro, T., Miwa, M., Nakagawa, H., Takamatsu, J., Oba, K., Fujimi, S., Kikuchi, H., Iwasawa, T., Kanbe, F., Oyama, K., et al. (2024) · Vaccine · doi:10.1016/j.vaccine.2023.12.033 · Cited by 11 · see citing works

mRNA COVID-19 Vaccine Effectiveness Against Severe Outcomes Among Adults Hospitalized with COVID-19 from May 2021 to January 2023

Ess, G., Lew, A. S., Tippett, A., Salazar, L. W., Choi, C., Castro, K. D., Taylor, E. G., Reese, O., Momin, H., Ciric, C. R., et al. (2025) · Vaccines · doi:10.3390/vaccines14010045

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

Tenforde, M. W., Patel, M. M., Ginde, A. A., Douin, D. J., Talbot, H. K., Casey, J. D., Mohr, N. M., Zepeski, A. E., Gaglani, M., McNeal, T., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab687 · Cited by 149 · see citing works

Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19—VISION Network, August 2021 to March 2022

DeSilva, M. B., Mitchell, P. K., Klein, N. P., Dixon, B. E., Tenforde, M. W., Thompson, M. G., Naleway, A. L., Grannis, S. J., Ong, T. C., Natarajan, K., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac458 · Cited by 14 · see citing works